Press releases

WASHINGTON – Sen. John Kennedy (R-La.) today introduced an amendment to the Inflation Reduction Act of 2022 to lower the cost of insulin.

“Louisianians and all Americans who suffer from diabetes know that the rising cost of insulin can be a matter of life or death. My amendment cuts prices by redirecting misused Obamacare funds to community health centers to help them pay for the lifesaving drug for middle and low-income individuals,” said Kennedy. 

Kennedy’s amendment repurposes funding from the Affordable Care Act to ensure that Federally Qualified Health Centers can provide discounted insulin and epinephrine for low and middle-income Americans in need.

Text of the amendment is available here.